Nob Hill Therapeutics Awarded HHS Phase II Grant and Announces New CEO
Albuquerque, NM - Nob Hill Therapeutics (NHT), a VIC Technology Venture Development portfolio company, announced today that it has received an HHS phase II grant (up to $1.73M) to develop an inhaled therapy to treat...